Literature DB >> 3181201

Short stature: a common feature in Duchenne muscular dystrophy.

U Eiholzer1, E Boltshauser, D Frey, L Molinari, M Zachmann.   

Abstract

In a retrospective growth evaluation, which included parental height, birth length and a longitudinal analysis of growth and bone maturation, it has been shown that short stature is a common finding in Duchenne muscular dystrophy already in an early or even preclinical stage. Normal length and weight at birth, slow subsequent growth with a curve crossing the centiles in the 1st years of life, and normal bone maturation are characteristic of this type of short stature.

Entities:  

Mesh：

Year:  1988        PMID： 3181201     DOI： 10.1007/bf00442472

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  18 in total

1.  [Body measurements, growth velocity and bone age of healthy children up to 12 years of age (longitudinal growth study Zurich) (author's trnasl)].

Authors:  A Prader; H Budliger
Journal:  Helv Paediatr Acta       Date:  1977

2.  Further evidence for Xp21 location of Duchenne muscular dystrophy (DMD) locus: X;9 translocation in a female with DMD.

Authors:  B S Emanuel; E H Zackai; S H Tucker
Journal:  J Med Genet       Date:  1983-12       Impact factor: 6.318

Review 3.  Structural anomalies of the X chromosome: personal observation and review of non-mosaic cases.

Authors:  D Wyss; C D DeLozier; J Daniell; E Engel
Journal:  Clin Genet       Date:  1982-02       Impact factor: 4.438

4.  Clinical and cytogenetic aspects of X-chromosome deletions.

Authors:  B Goldman; P E Polani; M G Daker; R R Angell
Journal:  Clin Genet       Date:  1982-01       Impact factor: 4.438

5.  Duchenne muscular dystrophy, glycerol kinase deficiency, and adrenal insufficiency associated with Xp21 interstitial deletion.

Authors:  J A Bartley; S Patil; S Davenport; D Goldstein; J Pickens
Journal:  J Pediatr       Date:  1986-02       Impact factor: 4.406

6.  Catch-up growth.

Authors:  A Prader
Journal:  Postgrad Med J       Date:  1978       Impact factor: 2.401

7.  Duchenne muscular dystrophy (DMD) in a female with an X/autosome translocation: further evidence that the DMD locus is at Xp21.

Authors:  P A Jacobs; P A Hunt; M Mayer; R D Bart
Journal:  Am J Hum Genet       Date:  1981-07       Impact factor: 11.025

8.  Turner's syndrome and Duchenne muscular dystrophy in a girl with an X; autosome translocation.

Authors:  L Bjerglund Nielsen; I M Nielsen
Journal:  Ann Genet       Date:  1984

9.  Longitudinal anthropometric measurements in patients with growth hormone deficiency. Effect of human growth hormone treatment.

Authors:  W Sorgo; M Zachmann; D Tassinari; F Fernandez; A Prader
Journal:  Eur J Pediatr       Date:  1982-02       Impact factor: 3.183

10.  Congenital adrenal hypoplasia, progressive muscular dystrophy, and severe mental retardation, in association with glycerol kinase deficiency, in male sibs.

Authors:  W O Renier; F A Nabben; T W Hustinx; J H Veerkamp; B J Otten; H J Ter Laak; B G Ter Haar; F J Gabreëls
Journal:  Clin Genet       Date:  1983-10       Impact factor: 4.438
View more
  12 in total

Review 1.  Growth, pubertal development, and skeletal health in boys with Duchenne Muscular Dystrophy.

Authors:  Leanne M Ward; David R Weber
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2019-02       Impact factor: 3.243

2.  Duchenne muscular dystrophy presenting with failure to thrive.

Authors:  R Rapisarda; F Muntoni; P Gobbi; V Dubowitz
Journal:  Arch Dis Child       Date:  1995-05       Impact factor: 3.791

3.  Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy.

Authors:  S Hodgson; K Hart; S Abbs; J Heckmatt; E Rodillo; M Bobrow; V Dubowitz
Journal:  J Med Genet       Date:  1989-11       Impact factor: 6.318

Review 4.  Cardiovascular Disease in Duchenne Muscular Dystrophy: Overview and Insight Into Novel Therapeutic Targets.

Authors:  Taylor I Schultz; Frank J Raucci; Fadi N Salloum
Journal:  JACC Basic Transl Sci       Date:  2022-03-09

5.  Beware of missed diagnosis in patients with multiple genetic diseases: a case report.

Authors:  Detong Guo; Xuemei Li; Nan Liu; Xiaoli Yu; Jianbo Shu; Wenchao Sheng; Dong Li; Chunquan Cai
Journal:  BMC Pediatr       Date:  2022-07-20       Impact factor: 2.567

6.  Obesity and Endocrine Management of the Patient With Duchenne Muscular Dystrophy.

Authors:  David R Weber; Stasia Hadjiyannakis; Hugh J McMillan; Garey Noritz; Leanne M Ward
Journal:  Pediatrics       Date:  2018-10       Impact factor: 7.124

7.  The role of muscle cells in regulating cartilage matrix production.

Authors:  Dana M Cairns; Philip G Lee; Tomoya Uchimura; Christopher R Seufert; Heenam Kwon; Li Zeng
Journal:  J Orthop Res       Date:  2010-04       Impact factor: 3.494

8.  Muscle cells enhance resistance to pro-inflammatory cytokine-induced cartilage destruction.

Authors:  Dana M Cairns; Tomoya Uchimura; Heenam Kwon; Philip G Lee; Christopher R Seufert; Elizabeth Matzkin; Li Zeng
Journal:  Biochem Biophys Res Commun       Date:  2009-12-31       Impact factor: 3.575

9.  Histologic muscular history in steroid-treated and untreated patients with Duchenne dystrophy.

Authors:  Lorenzo Peverelli; Silvia Testolin; Luisa Villa; Adele D'Amico; Stefania Petrini; Chiara Favero; Francesca Magri; Lucia Morandi; Marina Mora; Tiziana Mongini; Enrico Bertini; Monica Sciacco; Giacomo P Comi; Maurizio Moggio
Journal:  Neurology       Date:  2015-10-23       Impact factor: 9.910

10.  Growth hormone deficiency in a patient with becker muscular dystrophy: a pediatric case report.

Authors:  Valeria Calcaterra; Annachiara Malvezzi; Rossana Toglia; Angela Berardinelli; Elena Bozzola; Mauro Bozzola; Daniela Larizza
Journal:  Case Rep Endocrinol       Date:  2013-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.